FITB vs TBPH · P/E 17, rev $3.37B vs P/E 7.5, rev $38.4M
Fifth Third Bancorp (FITB) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the FITB and TBPH stock pages for the full models.
Not investment advice.